ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 120

Validity of the Inpatient Diagnosis of Systemic Lupus Erythematosus: Clarifying Hospital Readmission Rates

Sadiq Ali1, Stephen Mullis2, Amer Al-Khoudari1 and Dennis Ang1, 1Section on Rheumatology and Immunology, Wake Forest University, Winston Salem, NC, 2Department of Internal Medicine, Wake Forest University, Winston Salem, NC

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: ICD-9 and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Health Services Research Poster I: Diagnosis, Management and Treatment Strategies

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is assumed to be associated with one of the highest hospital readmission rates among chronic illnesses. Based on a recently published (Arth Rheumatol (2014) 66:2828) electronic database analysis of Medicare/Medicaid hospital discharges, 16.5% of patients with the ICD-9-CM code 710.0 for SLE were readmitted to any hospital within 30 days. Our long–term research goals are to determine the 30-day all-cause readmission rate for adults with SLE in our tertiary care hospital, and to identify the risk factors for readmission. The aim of the current report was to determine the validity of SLE diagnosis among our hospitalized patients with an ICD-9-CM code of 710.0.

Methods: Potential admissions were identified through the electronic medical record system (EMR). From October 1, 2012 to December 30, 2014, index admissions were defined as hospital admissions from adult patients (≥ 18 years of age) who had a primary or secondary ICD-9-CM diagnosis of 710.0. Individual charts were then manually reviewed by a single rheumatology fellow to determine if the patient fulfilled the 1997 ACR revised criteria for SLE. Chart review included analysis of all documents dated as far back as the implementation of the EMR in 1997, including clinical visits, imaging studies and laboratory results.

Results: 1003 index admissions met our inclusion criteria, obtained from 433 unique patients.  Only 196 (45%) of 433 patients fulfilled criteria for SLE.  237 (55%) patients did not meet criteria: 185 (43%) patients had an inappropriate diagnosis of SLE (i.e., chart review contained sufficient data to support an alternate diagnosis), 34 (8%) patients had limited cutaneous lupus, and 18 (4%) patients had insufficient data to either confirm or refute a diagnosis of SLE.

Conclusion:   Our initial result demonstrates a 55% rate of miscoding of hospital records for adult patients with a primary or secondary diagnosis of SLE designated by the ICD-9-CM code 710.0. Our result brings into question the use of ICD-9-CM coding to evaluate readmission data in SLE.


Disclosure: S. Ali, None; S. Mullis, None; A. Al-Khoudari, None; D. Ang, None.

To cite this abstract in AMA style:

Ali S, Mullis S, Al-Khoudari A, Ang D. Validity of the Inpatient Diagnosis of Systemic Lupus Erythematosus: Clarifying Hospital Readmission Rates [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/validity-of-the-inpatient-diagnosis-of-systemic-lupus-erythematosus-clarifying-hospital-readmission-rates/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validity-of-the-inpatient-diagnosis-of-systemic-lupus-erythematosus-clarifying-hospital-readmission-rates/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology